Patents by Inventor Yoshiaki Horiguchi

Yoshiaki Horiguchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7608627
    Abstract: A compound represented by the formula wherein R1, R2, R3 and R6 are the same or different and each is a hydrogen atom or a substituent; one of R4 and R5 is a hydrogen atom and the other is a group represented by the formula: —C(?X)—R7 wherein X is N—O—R8 or N—NH—R9 wherein R8 and R9 are the same or different and each is a hydrogen atom or a group bonded via a carbon atom; and R7 is a hydrogen atom or a substituent, and the like and a salt thereof have a superior I?B kinase inhibitory activity, and useful as pharmaceutical agents such as agents for preventing or treating diabetes and the like.
    Type: Grant
    Filed: April 4, 2005
    Date of Patent: October 27, 2009
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Yoshiaki Horiguchi, Hiroshi Imoto, Mark A. Wolf
  • Publication number: 20080064715
    Abstract: A compound represented by the formula wherein R1, R2, R3 and R6 are the same or different and each is a hydrogen atom or a substituent; one of R4 and R5 is a hydrogen atom and the other is a group represented by the formula: —C(?X)—R7 wherein X is N—O—R8 or N—NH—R9 wherein R8 and R9 are the same or different and each is a hydrogen atom or a group bonded via a carbon atom; and R7 is a hydrogen atom or a substituent, and the like and a salt thereof have a superior I?B kinase inhibitory activity, and useful as pharmaceutical agents such as agents for preventing or treating diabetes and the like.
    Type: Application
    Filed: April 4, 2005
    Publication date: March 13, 2008
    Inventors: Yoshiaki Horiguchi, Hiroshi Imoto, Mark A. Wolf